Alopecia areata Trials in Boston, United States
Conditions / Alopecia areata / Boston, United States
Clinical trials for Alopecia areata investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06873945 | A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata | RECRUITING | PHASE3 |
| NCT05084417 | A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions | UNKNOWN | — |
| NCT03570749 | A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata | COMPLETED | — |
| NCT04518995 | Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) | COMPLETED | PHASE3 |
| NCT03899259 | A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata | COMPLETED | PHASE3 |
| NCT06012240 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata | RECRUITING | — |
| NCT04006457 | Long-Term PF-06651600 for the Treatment of Alopecia Areata | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03732807 | PF-06651600 for the Treatment of Alopecia Areata | COMPLETED | PHASE2/PHASE3 |
| NCT03570749 | A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata | COMPLETED | — |
| NCT03898479 | Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |